In the United States, the Food and Drug Administration (FDA) regulates skincare cream packaging under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and associated regulations. While the FDA does not “approve” cosmetic packaging in the same way it approves drugs, it enforces strict requirements to ensure that packaging is safe, sanitary, and accurately labeled. Non-compliance can result in warning letters, product seizures, or even criminal charges.

A 2025 FDA enforcement report revealed that 27% of cosmetic packaging violations were related to misleading claims, 22% involved material safety issues, and 18% stemmed from inadequate labeling. For cream products—often water-based, oil-rich, and used directly on the skin—the stakes are especially high, as packaging defects can lead to contamination, chemical migration, or consumer harm.

This guide breaks down the key FDA compliance requirements for cream packaging, covering material safety, labeling rules, prohibited substances, and best practices for maintaining regulatory adherence.

1. Material Safety: Preventing Chemical Migration

The FDA considers cream packaging an “indirect food additive” when it contacts skincare products, which are regulated as cosmetics. This means packaging materials must not transfer harmful substances to the product under normal use conditions.

Key Regulations

21 CFR Part 177: Lists acceptable materials for food and cosmetic contact, including:

Plastics: PET, HDPE, PP, LDPE (free from BPA, phthalates, and vinyl chloride).

Glass: Borosilicate or soda-lime glass, free from lead and cadmium.

Metals: Aluminum, stainless steel, and tinplate, with food-grade internal liners.

Paperboard: Untreated or coated with FDA-compliant barrier materials.

21 CFR Part 175: Covers adhesives, coatings, and inks used in packaging. These must not migrate into the product in unsafe amounts.

Prohibited or Restricted Materials

PVC (Polyvinyl Chloride): Contains phthalates, which are endocrine-disrupting chemicals (EDCs) and potential carcinogens.

Polycarbonate (PC): Leaches bisphenol A (BPA), linked to hormonal disruption.

Lead and Cadmium: Heavy metals that can migrate from colored inks or metal closures.

Formaldehyde-Releasing Agents: Used in some adhesives or coatings; classified as a probable human carcinogen.

PFAS (Perfluoroalkyl Substances): Emerging concern due to environmental persistence and health risks.

Best Practices

Request Certificates of Compliance (CoC): From suppliers confirming materials meet 21 CFR standards.

Avoid Recycled Materials Without Testing: Recycled plastics may contain contaminants; ensure they are reprocessed to remove impurities.

Conduct Migration Testing: Simulate product contact over time to verify no harmful substances leach into the cream.

2. Labeling Requirements: Truthful, Legible, and Comprehensive

FDA labeling rules (21 CFR Parts 701 and 740) govern what must appear on cream packaging, where, and how.

Required Label Elements

Principal Display Panel (PDP)

Identity Statement: The product’s common or usual name (e.g., “Hydrating Face Cream”).

Net Quantity: Metric and U.S. customary units (e.g., “50 g / 1.76 oz”).

Brand Name: Prominently displayed.

Information Panel

Ingredient List: INCI (International Nomenclature of Cosmetic Ingredients) names in descending order by concentration.

Trade Secrets: Fragrance or flavor formulas may be listed as “Fragrance (Parfum)” if disclosed to the FDA.

Name and Address: Manufacturer, packer, or distributor (including street address, city, state, and ZIP code).

Warnings: Required for products posing risks (e.g., “For external use only,” “Avoid contact with eyes”).

Directions for Use: Clear instructions (e.g., “Apply twice daily to clean skin”).

Additional Requirements

Legibility: Text must be at least 1/16 inch (1.6 mm) in height for most labels; smaller text allowed for secondary panels.

Language: All mandatory information must be in English.

Accuracy: No false or misleading claims (e.g., “FDA-approved” for a cosmetic, which is illegal).

Common Labeling Violations

Omitting Net Quantity: A frequent FDA citation, especially for travel-sized creams.

Incorrect INCI Names: Using trade names instead of standardized INCI identifiers (e.g., “Vitamin E” instead of “Tocopherol”).

Unsubstantiated Claims: “Anti-aging,” “hypoallergenic,” or “dermatologist-tested” require supporting data.

3. Good Manufacturing Practices (GMP) for Cream Packaging

The FDA’s GMP guidelines (21 CFR Part 700) require packaging processes to be sanitary and consistent:

Facility Requirements

Cleanliness: Packaging areas must be free from pests, dust, and contaminants.

Equipment Maintenance: Regular calibration and cleaning to prevent cross-contamination.

Employee Hygiene: Staff handling packaging must follow hygiene protocols (e.g., gloves, hairnets).

Documentation

Batch Records: Track packaging materials, production dates, and quality checks.

Change Control: Document any changes to packaging suppliers, materials, or processes.

Recall Procedures: Have a plan to remove defective packaging from the market.

4. Advertising and Promotional Materials

While not strictly “packaging,” promotional materials (e.g., product inserts, website ads) must comply with FDA rules:

No Drug Claims: Cosmetics cannot claim to treat or prevent disease (e.g., “cures eczema”).

Truthful Claims: Substantiate all performance claims (e.g., “hydrates for 24 hours” requires testing).

Fair Balance: Avoid exaggeration or misleading imagery (e.g., showing dramatic before/after results without proof).

5. Recent FDA Enforcement Trends

The FDA has increased scrutiny on:

PFAS in Packaging: Issued warning letters to brands using PFAS-containing paperboard or coatings.

Online Sales: Monitoring e-commerce listings for misleading packaging claims (e.g., “FDA-approved” on Amazon).

Imported Packaging: Rejecting shipments with non-compliant materials or labeling.

6. How to Achieve and Maintain Compliance

Step 1: Conduct a Packaging Audit

Review all materials, labels, and suppliers against FDA regulations.

Step 2: Partner with FDA-Experienced Suppliers

Choose vendors familiar with 21 CFR requirements and able to provide CoCs.

Step 3: Test Rigorously

Perform migration testing, material safety analysis, and label legibility checks.

Step 4: Stay Updated

Subscribe to the FDA’s email alerts and attend industry webinars (e.g., Society of Cosmetic Chemists events).

Case Studies: FDA Actions Against Non-Compliant Cream Packaging

1. Phthalate-Containing Jars

In 2023, the FDA issued a warning letter to a skincare brand using PVC jars for its vitamin C cream. Testing showed phthalate migration exceeding safe limits. The brand recalled products and switched to HDPE jars.

2. Misleading “FDA-Approved” Claims

A startup marketed its night cream as “FDA-approved for sensitive skin.” The FDA deemed this false advertising, as cosmetics are not subject to pre-market approval. The company faced fines and removed the claim from all packaging and ads.

Conclusion: Compliance as a Foundation of Trust

FDA compliance for cream packaging is not just a legal hurdle—it’s a framework for ensuring consumer safety and brand integrity. By prioritizing material safety, accurate labeling, and sanitary manufacturing, you protect both your customers and your business.

In an industry where trust is everything, FDA compliance is your first step toward building a reputable, resilient brand.

Ready to ensure your cream packaging meets FDA standards? Download our FDA Cream Packaging Compliance Checklistto guide your audits, testing, and supplier partnerships.

Minimalist Cream Packaging Ideas for High-End Cosmetic Brands

Cream Packaging Materials: Glass vs Plastic – Which Is Better?